Nebulizer versus handheld inhaler for severe lung disease

Plain-English translation of NCT07816835 on ClinicalTrials.gov ↗ · Source last updated September 2026 · Translation generated September 2026 · How we translate trials

Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.

What is this trial?

This trial is testing whether delivering your regular maintenance medications through a nebulizer machine (which creates a mist you breathe in) works better than using your current handheld inhaler. Researchers believe a nebulizer may deliver the medication more effectively into your lungs, especially if you sometimes have trouble using a handheld inhaler correctly. The study will compare how well each method helps reduce breathing difficulty and improves your quality of life.

Many people with severe lung disease struggle to use handheld inhalers correctly every day, which means they may not get the full benefit of their medication. A nebulizer delivers smaller medication particles deeper into the lungs, and this trial wants to find out if this method actually helps patients breathe better and feel healthier than continuing with handheld inhalers.

Do you qualify?

You likely qualify if…

you have a diagnosis of severe to very severe chronic obstructive pulmonary disease based on standard criteria
you have smoked at least 10 pack-years of cigarettes in your lifetime
you have been clinically stable without flare-ups for the past 4 weeks
your lung function tests from the past year show significant airway obstruction
you are currently using a single maintenance inhaler (either a combination of long-acting medications or long-acting with inhaled steroid) for at least one month

You likely don't qualify if…

you have been diagnosed with dementia or cognitive impairment that would make it hard to participate
you have severe hand problems like advanced arthritis or tremors that prevent you from using inhalers correctly
you have had a flare-up of your lung disease within the past 2 months
you are currently taking daily prednisone as treatment for your lung disease
you have been diagnosed with another respiratory disease like asthma or are already using certain nebulized rescue medications multiple times daily

What participation looks like

If you join this trial, you will be randomly assigned to either continue using your current handheld inhaler or switch to receiving the same medications through a nebulizer machine at home. You will be asked to use your assigned device as prescribed and attend visits where researchers will measure your breathing, ask about your symptoms, and assess how you're feeling overall. The study will track how your breathing and quality of life improve over time with each delivery method.

AI-generated summary from trial data · Sep 15, 2026 · Not medical advice

Trial locations(2 sites)

United States

Midwest Chest Consultants, P.C., Saint Charles, Missouri

Southeastern Research Center, Winston-Salem, North Carolina